Abstract
This study quantifies antispike protein antibody responses to first-dose messenger RNA (mRNA) COVID-19 vaccines in solid organ transplant recipients to better understand the immunogenicity of the vaccines in immunocompromised individuals.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Aged
-
Antibodies, Viral / blood*
-
COVID-19 / immunology
-
COVID-19 / prevention & control*
-
COVID-19 Vaccines / immunology*
-
Female
-
Humans
-
Immunoenzyme Techniques
-
Immunogenicity, Vaccine*
-
Male
-
Middle Aged
-
Organ Transplantation
-
Prospective Studies
-
Spike Glycoprotein, Coronavirus / immunology*
-
Transplant Recipients*
-
Vaccines, Synthetic / immunology
-
mRNA Vaccines
Substances
-
Antibodies, Viral
-
COVID-19 Vaccines
-
Spike Glycoprotein, Coronavirus
-
Vaccines, Synthetic
-
spike protein, SARS-CoV-2